Effect of prednisolone and saireito co-administration on T-cells of rheumatoid arthritis patients.

Yamazaki, Kyosuke; Kiyomi, Anna; Imai, Shinobu; Sugiyama, Kentaro; Tahara, Koichiro; Sawada, Tetsuji; Sugiura, Munetoshi

Yamazaki, Kyosuke; Kiyomi, Anna; Imai, Shinobu; Sugiyama, Kentaro; Tahara, Koichiro; Sawada, Tetsuji; Sugiura, Munetoshi.

Afiliación

Yamazaki K; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan. y141193@toyaku.ac.jp.
Kiyomi A; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Imai S; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, and Division of Pharmacoepidemiology, Department of Healthcare and Regulatory Sciences, Showa University School of Pharmacy, Tokyo, Japan.
Sugiyama K; Department of Clinical Pharmacology, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.
Tahara K; Department of Rheumatology, Tokyo Medical University Hospital, Tokyo, Japan.
Sawada T; Department of Rheumatology, Tokyo Medical University Hospital, Tokyo, Japan.
Sugiura M; Department of Drug Safety and Risk Management, Tokyo University of Pharmacy and Life Sciences, Tokyo, Japan.

Clin Exp Rheumatol ; 41(9): 1777-1783, 2023 Sep.

Article en En | MEDLINE | ID: mdl-36826781

Asunto(s)

Antirreumáticos; Artritis Reumatoide; Adulto; Humanos; Prednisolona/efectos adversos; Antirreumáticos/efectos adversos; Leucocitos Mononucleares; Interleucina-6; Metotrexato/efectos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Reumatoide / Antirreumáticos Límite: Adult / Humans Idioma: En Revista: Clin Exp Rheumatol Año: 2023 Tipo del documento: Article País de afiliación: Japón

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google